Can e-Health improve post-marketing surveillance of drugs and vaccines? The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised controlled trial. [ 2013 - 2017 ]

Research Grant

Researchers: Prof Michael Gold (Principal investigator) ,  Dr Paul Effler ,  Prof Annette Braunack-Mayer ,  Prof Jim Buttery ,  Prof Kristine Macartney
View all 6 related researchers

Brief description Despite the considerable benefits of vaccination there is public concern about the safety of newly introduced or seasonal influenza vaccines. Loss of confidence in vaccine safety can result in decreased vaccine coverage and resurgence of disease. The current system of monitoring vaccines after licensure is unable to detect all important adverse events following immunisation. The proposed study evaluates web based communication and mobile phone text messaging to identify adverse events following immunisation.

Funding Amount $AUD 445,368.26

Funding Scheme Partnerships

Notes Partnership Project for Better Health